Canada Metabolic Inflammation Diagnostics Inc. practices in the usual practitioner referral system for both clinical and research practices. Patients are advised to be supervised and guided in regard to the interpretation of their results by a qualified health care practitioner and health care professionals.
Dr. Rafik Ragheb, Ph.D., a clinical scientist, Biochemist (CSCC) and Faculty for Laboratory Medicine and licensed health care professional practicing Medical Laboratory Sciences through CMLTO/CSMLS since 1996 and a licensed Laboratory Director in Ontario in the class of Biochemistry since 1999. Dr. Ragheb founded CMID Inc. in 2015. His novel idea and approach has been registered as an intellectual property through Canadian Intellectual property office: Industry Canada-Certificate of Registration NO (1077959).
Our general objective is to use the cytokine array panel test as a clinical and a research tool for early prediction, prevention and intervention. This is an informative and applicable to different disease states as insulin resistance syndrome/ metabolic syndrome, Type 2 Diabetes, cardiovascular disorders, Rheumatic disorders, to name few as metrics in the management of chronic diseases.
Our testing panels is applicable for a wide range of diseases such as Diabetes, retinal diseases (Retinal Vein Occlusion, Diabetic Macular Edema and Age related Macular Degeneration), Immunological disorders, cardiovascular disorder, lipid disorders and cancer. Applications have significantly evolved with a wide range of novel and routine assays. Our services are suitable for use in a wide range of settings including Clinical, Research and Hospital laboratories.
Randox Laboratories Ltd.
55 Diamond Road, Crumlin,
BT29 4QY, United Kingdom